Neptune Wellness Solutions Inc. (NEPT) |
|
0.77 0.052 (7.18%)
|
01-27 16:00 |
|
Open: |
0.735 |
Pre. Close: |
0.7184 |
|
High:
|
0.7777 |
Low:
|
0.71 |
|
Volume:
|
227,000 |
Market Cap:
|
9(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:46:32 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.03 One year: 1.21 |
| Support: |
Support1: 0.48 Support2: 0.23 |
| Resistance: |
Resistance1: 0.88 Resistance2: 1.03 |
| Pivot: |
0.63 |
| Moving Average: |
MA(5): 0.73 MA(20): 0.56
MA(100): 1.06  MA(250): 3.63 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 70.9 %D(3): 78.6 |
| RSI: |
RSI(14): 63.7 |
| 52-week: |
High: 14.69 Low: 0.14 |
| Average Vol(K): |
3-Month: 1,051 (K) 10-Days: 456 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ NEPT ] has closed below upper band by 9.5%. Bollinger Bands are 50.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.78 - 0.78 |
0.78 - 0.79 |
|
Low:
|
0.7 - 0.71 |
0.71 - 0.71 |
|
Close:
|
0.76 - 0.77 |
0.77 - 0.78 |
|
Company Description |
|
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada. |
Headline News |
Fri, 27 Jan 2023
Brian Kilmeade raves about Jacksonville 'rebuild,' Neptune Beach ... - Florida Politics
Fri, 27 Jan 2023
Neptune murder trial: Her boyfriend was shot and barely breathing ... - Asbury Park Press
Thu, 26 Jan 2023
Neptune car crash on Route 66 kills bicyclist - Asbury Park Press
Wed, 25 Jan 2023
Consumer Sector Update for 01/25/2023: REAL, CTC-A.TO, NEPT ... - Nasdaq
Wed, 25 Jan 2023
Neptune Wellness Announces an Accounts Receivable Factoring ... - PR Newswire
Tue, 24 Jan 2023
Neptune NJ settles in police racial discrimination lawsuit - Asbury Park Press
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
12 (M) |
| Shares Float |
7 (M) |
|
% Held by Insiders
|
13.3 (%) |
|
% Held by Institutions
|
29.8 (%) |
|
Shares Short
|
479 (K) |
|
Shares Short P.Month
|
258 (K) |
Stock Financials |
|
EPS
|
-18.61 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
-0.03 |
|
EPS Est Next Year
|
-0.01 |
|
Book Value (p.s.)
|
1.35 |
|
Profit Margin (%)
|
-150.9 |
|
Operating Margin (%)
|
-116.4 |
|
Return on Assets (ttm)
|
-37.5 |
|
Return on Equity (ttm)
|
-152.3 |
|
Qtrly Rev. Growth
|
-4.2 |
|
Gross Profit (p.s.)
|
-0.73 |
|
Sales Per Share
|
4.64 |
|
EBITDA (p.s.)
|
-5.04 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-35 (M) |
|
Levered Free Cash Flow
|
-16 (M) |
Stock Valuations |
|
PE Ratio
|
-0.05 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.57 |
|
Price to Sales
|
0.16 |
|
Price to Cash Flow
|
-0.26 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
2008-07-23 |
|
Your Ad Here
|
|
